Literature DB >> 1617446

Fluoxetine shortens circadian period for wheel running activity in mice.

B Possidente1, A R Lumia, S McEldowney, M Rapp.   

Abstract

Fluoxetine is a potent and specific serotonin re-uptake inhibitor and an effective antidepressant drug. Male mice were treated with either fluoxetine (8 mg/kg body weight per day) or saline. Wheel running activity was monitored for 2 weeks in a 12:12 LD cycle followed by 2 weeks in constant darkness (DD). Fluoxetine significantly shortened free-running circadian period for wheel running activity (23.93 +/- 0.08 h for fluoxetine treated mice versus 24.17 +/- 0.07 h for saline treated mice; p less than 0.03). These results are consistent with a role for serotonin in the regulation of circadian period in mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617446     DOI: 10.1016/0361-9230(92)90114-d

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.

Authors:  Robert L Gannon; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2007-08-13       Impact factor: 4.530

2.  A mutation in CLOCK leads to altered dopamine receptor function.

Authors:  Sade Spencer; Melissa I Torres-Altoro; Edgardo Falcon; Rachel Arey; Marian Marvin; Matthew Goldberg; James A Bibb; Colleen A McClung
Journal:  J Neurochem       Date:  2012-07-27       Impact factor: 5.372

Review 3.  Pharmacological Manipulation of the Circadian Clock: A Possible Approach to the Management of Bipolar Disorder.

Authors:  Alessandra Porcu; Robert Gonzalez; Michael J McCarthy
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

4.  Neonatal desipramine treatment alters free-running circadian drinking rhythms in rats.

Authors:  A M Rosenwasser; M J Hayes
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 5.  Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus.

Authors:  Chelsea A Vadnie; Colleen A McClung
Journal:  Neural Plast       Date:  2017-11-05       Impact factor: 3.599

Review 6.  Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging.

Authors:  Gabrielle F Gloston; Seung-Hee Yoo; Zheng Jake Chen
Journal:  Front Neurol       Date:  2017-03-15       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.